Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Absci Corp (BSCI) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2023 8-K Quarterly results
08/14/2023 8-K Quarterly results
Docs: "Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results Entered into partnership with Google Ventures-backed biotech company to discover innovative new medicines",
"Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer Addition of veteran biotech leader to further support Absci’s next stage of growth"
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
06/16/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
06/16/2023 8-K Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submiss...
Docs: "ABSCI CORPORATION $100,000,000 COMMON STOCK SALES AGREEMENT",
"AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ABSCI CORPORATION",
"3 Embarcadero Center San Francisco, CA 94111"
06/06/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of Philips"
05/30/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
05/08/2023 SC 13D/A Casdin Capital, LLC reports a 4.8% stake in Absci Corporation
03/20/2023 SC 13D/A Casdin Capital, LLC reports a 6% stake in Absci Corporation
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023 SC 13G/A Phoenix Venture Partners II LP reports a 15.7% stake in Absci Corporation
02/13/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/13/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/09/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/16/2022 8-K Quarterly results
11/09/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/09/2022 8-K Quarterly results
11/02/2022 8-K Quarterly results
10/04/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer Dr. Busch transitions from Absci’s Board of Directors to Absci’s Executive Leadership team"
09/20/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
09/06/2022 EFFECT Form EFFECT - Notice of Effectiveness:
08/24/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
08/11/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/11/2022 8-K Quarterly results
07/20/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/14/2022 8-K Quarterly results
06/10/2022 8-K Quarterly results
05/11/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/11/2022 8-K Quarterly results
04/26/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/26/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/22/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/22/2022 10-K Annual Report for the period ended December 31, 2021
03/22/2022 8-K Quarterly results
Docs: "Absci Reports Full Year 2021 Financial and Operating Results",
"Absci Develops Groundbreaking Machine Learning Models for In-Silico Antibody Design, Powered by NVIDIA Absci to present in-silico drug discovery technology at NVIDIA GTC"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy